Clinical Trial Update: Effects of Gardemont S.A Food Supplement on Upper Respiratory Illness [Phase 2]

View source ↗

Summary

Phase 2 trial update on the effects of a Gardemont S.A. food supplement for upper respiratory illness; the current status is Unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• Gardemont S.A Food Supplement

Snippet

Sponsor: Meir Medical Center | Conditions: Respiratory Infections | Phase 2 | Status: UNKNOWN